Substitutions Available For Shortage Of Dapsone 25 Mg Tablets

Dapsone 25 mg Tablet Shortage Dapsone 25 mg tablets are currently in short supply across Australia. During this shortage, Dapsone 50 mg tablets are available as a substitute and can be cut in half to provide the equivalent dose. This is classified as a Class III recall affecting all Australian consumers who use this medication.

Reason
Dapsone 50 mg tablets can be supplied and halved during the shortage.
Classification
Class III
Category
drug recall
Country
Australia
Agency
Therapeutic Goods Administration
Recall date
2026-08-14
Status
Ongoing
Distribution
Australia-wide

Official recall notice from Therapeutic Goods Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/6de927a6-4f21-442f-9b01-d927913d647f